UBU5:F:F-UBS (Irl) ETF Public Limited Company - MSCI USA Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 110.72

Change

0.00 (0.00)%

Market Cap

USD 0.75B

Volume

180.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.29 (+0.51%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.02 (+0.02%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.01 (+0.00%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.15 (+1.30%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.14%)

USD 43.12B
0ZC:F Zscaler Inc

-1.12 (-0.61%)

USD 37.92B

ETFs Containing UBU5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.52% 70% C- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.52% 69% C- 61% D-
Trailing 12 Months  
Capital Gain 20.36% 74% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.36% 71% C- 59% D-
Trailing 5 Years  
Capital Gain 46.22% 72% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.22% 71% C- 53% F
Average Annual (5 Year Horizon)  
Capital Gain 12.69% 78% C+ 70% C-
Dividend Return 12.69% 75% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.63% 49% F 83% B
Risk Adjusted Return 93.06% 88% B+ 92% A
Market Capitalization 0.75B 71% C- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.